Tumors treated with TTFields exhibit increased infiltration of immune cells, including CD45 + cells, CD4+, and CD8 + lymphocytes, creating an immunologically “hot” tumor microenvironment compared to untreated “cold” tumors [116, 117]. This evidence concerns the gene CD8A and neoplasm.